Menu

Two drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2022 and 2024.

GSK and Eli Lilly to Refund 340B Covered Entities for Overcharges

February 24, 2026 Shannon Young, Associate Editor/Senior Writer 340B Report Views

Two drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2022 and 2024. U.K. pharmaceutical giant [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

Hospital, Pharmacist Groups Urge HRSA to Extend Comment Deadline on 340B Rebate RFI

AEH Policy Paper Calls For 340B Contract Pharmacy Protections, Continued Up-Front Discounts